| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2020) |
Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France] | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. |
| 000015 (2020) |
Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France] | Repurposing antimalarials and other drugs for COVID-19. |
| 000019 (2020) |
Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France] | [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19]. |
| 000051 (2020) |
Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France] | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. |
| 000111 (2020) |
M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France] | [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. |
| 000117 (2020) |
L. Boyer [France] ; P. Auquier [France] ; G. Fond [France] | [Real-life data and Covid-19: The third avenue of reseach]. |
| 000152 (2020) |
H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France] | [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic]. |
| 000162 (2020) |
S. Touhami [France] ; D. Saadoun [France] ; L. Kodjikian [France] ; B. Bodaghi [France] | [How to approach follow-up of uveitis patients during the Covid-19 pandemic?] |
| 000180 (2020) |
A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France] | [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review]. |
| 000195 (2020) |
H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France] | [Challenges for psychotropics in the context of the SARS-Cov-2 pandemic]. |
| 000249 (2020) |
Elie Rassy [Liban] ; Rita-Maria Khoury-Abboud [Liban] ; Nathalie Ibrahim [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban] ; Joseph Kattan [Liban] | What the oncologist needs to know about COVID-19 infection in cancer patients. |
| 000268 (2020) |
Zhenlin Li [France] ; Denise Paulin [France] ; Patrick Lacolley [France] ; Dario Coletti [France, Italie] ; Onnik Agbulut [France] | Vimentin as a target for the treatment of COVID-19. |
| 000286 (2020) |
Frederic Sacher [France] ; Laurent Fauchier [France] ; Serge Boveda [France] ; Christian De Chillou [France] ; Pascal Defaye [France] ; Jean Claude Deharo [France] ; Estelle Gandjbakhch [France] ; Vincent Probst [France] ; Ariel Cohen [France] ; Christophe Leclercq [France] | Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection. |
| 000321 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19. |
| 000454 (2020) |
Derek C. Angus [États-Unis] ; Scott Berry [États-Unis] ; Roger J. Lewis [États-Unis] ; Farah Al-Beidh [Royaume-Uni] ; Yaseen Arabi [Arabie saoudite] ; Wilma Van Bentum-Puijk ; Zahra Bhimani [Canada] ; Marc Bonten ; Kristine Broglio [États-Unis] ; Frank Brunkhorst [Allemagne] ; Allen C. Cheng [Australie] ; Jean-Daniel Chiche [France] ; Menno De Jong [Pays-Bas] ; Michelle Detry [États-Unis] ; Herman Goossens [Belgique] ; Anthony Gordon [Royaume-Uni] ; Cameron Green [Australie] ; Alisa M. Higgins [Australie] ; Sebastiaan J. Hullegie ; Peter Kruger [Australie] ; Francois Lamontagne [Canada] ; Edward Litton [Australie] ; John Marshall [Canada] ; Anna Mcglothlin [États-Unis] ; Shay Mcguinness [Australie, Nouvelle-Zélande] ; Paul Mouncey [Royaume-Uni] ; Srinivas Murthy [Canada] ; Alistair Nichol [Australie, Irlande (pays)] ; Genevieve K. O'Neill [Australie] ; Rachael Parke [Nouvelle-Zélande] ; Jane Parker [Australie] ; Gernot Rohde [Allemagne] ; Kathryn Rowan [Royaume-Uni] ; Anne Turner [Nouvelle-Zélande] ; Paul Young [Nouvelle-Zélande] ; Lennie Derde [Pays-Bas] ; Colin Mcarthur [Nouvelle-Zélande] ; Steven A. Webb [Australie] | The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. |
| 000456 (2020) |
Edouard Alphandéry [France, Suisse] | The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. |
| 000467 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 000468 (2020) |
Mehdi Bouhaddou [États-Unis] ; Danish Memon [Royaume-Uni] ; Bjoern Meyer [France] ; Kris M. White [États-Unis] ; Veronica V. Rezelj [France] ; Miguel Correa Marrero [Royaume-Uni] ; Benjamin J. Polacco [États-Unis] ; James E. Melnyk ; Svenja Ulferts [Allemagne] ; Robyn M. Kaake [États-Unis] ; Jyoti Batra [États-Unis] ; Alicia L. Richards [États-Unis] ; Erica Stevenson [États-Unis] ; David E. Gordon [États-Unis] ; Ajda Rojc [États-Unis] ; Kirsten Obernier [États-Unis] ; Jacqueline M. Fabius [États-Unis] ; Margaret Soucheray [États-Unis] ; Lisa Miorin [États-Unis] ; Elena Moreno [États-Unis] ; Cassandra Koh [France] ; Quang Dinh Tran [France] ; Alexandra Hardy [France] ; Rémy Robinot [France] ; Thomas Vallet [France] ; Benjamin E. Nilsson-Payant [États-Unis] ; Claudia Hernandez-Armenta [Royaume-Uni] ; Alistair Dunham [Royaume-Uni] ; Sebastian Weigang [Allemagne] ; Julian Knerr [Allemagne] ; Maya Modak [États-Unis] ; Diego Quintero [États-Unis] ; Yuan Zhou [États-Unis] ; Aurelien Dugourd [Allemagne] ; Alberto Valdeolivas [Allemagne] ; Trupti Patil [États-Unis] ; Qiongyu Li [États-Unis] ; Ruth Hüttenhain [États-Unis] ; Merve Cakir [États-Unis] ; Monita Muralidharan [États-Unis] ; Minkyu Kim [États-Unis] ; Gwendolyn Jang [États-Unis] ; Beril Tutuncuoglu [États-Unis] ; Joseph Hiatt [États-Unis] ; Jeffrey Z. Guo [États-Unis] ; Jiewei Xu [États-Unis] ; Sophia Bouhaddou [États-Unis] ; Christopher J P. Mathy [États-Unis] ; Anna Gaulton [Royaume-Uni] ; Emma J. Manners [Royaume-Uni] ; Eloy Félix [Royaume-Uni] ; Ying Shi ; Marisa Goff [États-Unis] ; Jean K. Lim [États-Unis] ; Timothy Mcbride [États-Unis] ; Michael C. O'Neal [États-Unis] ; Yiming Cai [États-Unis] ; Jason C J. Chang [États-Unis] ; David J. Broadhurst [États-Unis] ; Saker Klippsten [États-Unis] ; Emmie De Wit [États-Unis] ; Andrew R. Leach [Royaume-Uni] ; Tanja Kortemme [États-Unis] ; Brian Shoichet [États-Unis] ; Melanie Ott [États-Unis] ; Julio Saez-Rodriguez [Allemagne] ; Benjamin R. Tenoever [États-Unis] ; R Dyche Mullins ; Elizabeth R. Fischer [États-Unis] ; Georg Kochs [Allemagne] ; Robert Grosse [Allemagne] ; Adolfo García-Sastre [États-Unis] ; Marco Vignuzzi [France] ; Jeffery R. Johnson [États-Unis] ; Kevan M. Shokat [États-Unis] ; Danielle L. Swaney [États-Unis] ; Pedro Beltrao [Royaume-Uni] ; Nevan J. Krogan [États-Unis] | The Global Phosphorylation Landscape of SARS-CoV-2 Infection. |
| 000535 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000536 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000541 (2020) |
Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis] | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. |
| 000621 (2020) |
Atul Sharma [Australie] ; Swapnil Tiwari [Inde] ; Manas Kanti Deb [Inde] ; Jean Louis Marty [France] | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. |
| 000622 (2020) |
Sébastien Nisole [France] ; Aure Saulnier ; Anne Gatignol [Canada] | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease? |
| 000700 (2020) |
Daria Sicari [France, Italie] ; Aristotelis Chatziioannou [Grèce] ; Theodoros Koutsandreas [Grèce] ; Roberto Sitia [Italie] ; Eric Chevet [France, Italie] | Role of the early secretory pathway in SARS-CoV-2 infection. |
| 000718 (2020) |
P C Fragkou [Suisse] ; D. Belhadi [France] ; N. Peiffer-Smadja [France] ; C D Moschopoulos [Grèce] ; F-X Lescure [France] ; H. Janocha [Allemagne] ; E. Karofylakis [Grèce] ; Y. Yazdanpanah [France] ; F. Mentré [France] ; C. Skevaki [Allemagne] ; C. Laouénan [France] ; S. Tsiodras [Suisse] | Review of trials currently testing treatment and prevention of COVID-19. |
| 000759 (2020) |
M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France] | Repurposing chlorpromazine to treat COVID-19: The reCoVery study. |
| 000774 (2020) |
Ashleigh Shannon [France] ; Nhung Thi-Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [France] ; Francois Ferron [France] ; Bruno Canard [France] | Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. |
| 000776 (2020) |
Alan G. Fraser [Royaume-Uni, Belgique] ; Piotr Szyma Ski [Pologne] ; Elizabeth Macintyre [France] ; Martin Landray [Royaume-Uni] | Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? |
| 000820 (2020) |
Marc Montana [France] ; Vincent Montero [France] ; Omar Khoumeri [France] ; Patrice Vanelle [France] | Quinoxaline Derivatives as Antiviral Agents: A Systematic Review. |
| 000889 (2020) |
S. Tunesi [France] ; A. Bourgarit [France] | Prescribing COVID-19 treatments: what we should never forget. |
| 000921 (2020) |
Nicolas Venisse [France] | Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. |
| 000922 (2020) |
Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France] | Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. |
| 000949 (2020) |
Behnood Bikdeli [États-Unis] ; Mahesh V. Madhavan [États-Unis] ; Aakriti Gupta [États-Unis] ; David Jimenez [Espagne] ; John R. Burton [États-Unis] ; Caroline Der Nigoghossian [États-Unis] ; Taylor Chuich [États-Unis] ; Shayan Nabavi Nouri [États-Unis] ; Isaac Dreyfus [États-Unis] ; Elissa Driggin [États-Unis] ; Sanjum Sethi [États-Unis] ; Kartik Sehgal [États-Unis] ; Saurav Chatterjee [États-Unis] ; Walter Ageno [Italie] ; Mohammad Madjid [États-Unis] ; Yutao Guo [République populaire de Chine, Royaume-Uni] ; Liang V. Tang [République populaire de Chine] ; Yu Hu [République populaire de Chine] ; Laurent Bertoletti [France] ; Jay Giri [États-Unis] ; Mary Cushman [États-Unis] ; Isabelle Quéré [France] ; Evangelos P. Dimakakos [Grèce] ; C Michael Gibson [États-Unis] ; Giuseppe Lippi [Italie] ; Emmanuel J. Favaloro [Australie] ; Jawed Fareed [États-Unis] ; Alfonso J. Tafur [États-Unis] ; Dominic P. Francese [États-Unis] ; Jaya Batra [États-Unis] ; Anna Falanga [Italie] ; Kevin J. Clerkin [États-Unis] ; Nir Uriel [États-Unis] ; Ajay Kirtane [États-Unis] ; Claire Mclintock [Nouvelle-Zélande] ; Beverley J. Hunt [Royaume-Uni] ; Alex C. Spyropoulos [États-Unis] ; Geoffrey D. Barnes [États-Unis] ; John W. Eikelboom [Canada] ; Ido Weinberg [États-Unis] ; Sam Schulman [Russie, Canada] ; Marc Carrier [Canada] ; Gregory Piazza [États-Unis] ; Joshua A. Beckman [États-Unis] ; Martin B. Leon [États-Unis] ; Gregg W. Stone [États-Unis] ; Stephan Rosenkranz [Allemagne] ; Samuel Z. Goldhaber [États-Unis] ; Sahil A. Parikh [États-Unis] ; Manuel Monreal [Espagne] ; Harlan M. Krumholz [États-Unis] ; Stavros V. Konstantinides [Allemagne] ; Jeffrey I. Weitz [Canada] ; Gregory Y H. Lip [Royaume-Uni, Danemark] | Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. |
| 000950 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions. |
| 000996 (2020) |
Amélie Soumier [France] ; Angela Sirigu [France] | Oxytocin as a potential defence against Covid-19? |
| 000A15 (2020) |
Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède] | On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. |
| 000A31 (2020) |
Franck Touret [France] ; Xavier De Lamballerie [France] | Of chloroquine and COVID-19. |
| 000A53 (2020) |
J M Molina [France] ; C. Delaugerre [France] ; J. Le Goff [France] ; B. Mela-Lima [France] ; D. Ponscarme [France] ; L. Goldwirt [France] ; N. De Castro [France] | No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. |
| 000A60 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 000B08 (2020) |
Roberto Gomeni [France] ; Tianhong Xu [République populaire de Chine] ; Xuejuan Gao [République populaire de Chine] ; Françoise Bressolle-Gomeni [France] | Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2. |
| 000B26 (2020) |
Abdelouaheb Benani [Maroc] ; Sanae Ben Mkaddem [France] | Mechanisms Underlying Potential Therapeutic Approaches for COVID-19. |
| 000B81 (2020) |
Christophe Beyls [France] ; Nicolas Martin [France] ; Alexis Hermida [France] ; Osama Abou-Arab [France] ; Yazine Mahjoub [France] | Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia. |
| 000B90 (2020) |
Rami Bou Khalil [Liban] | Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia. |
| 000C17 (2020) |
Derek Hazard [Allemagne] ; Klaus Kaier [Allemagne] ; Maja Von Cube [Allemagne] ; Marlon Grodd [Allemagne] ; Lars Bugiera [Allemagne] ; Jerome Lambert [Allemagne, France] ; Martin Wolkewitz [Allemagne] | Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach. |
| 000C51 (2020) |
Margarida Sa Ribero [France] ; Nolwenn Jouvenet [France] ; Marlène Dreux [France] ; Sébastien Nisole [France] | Interplay between SARS-CoV-2 and the type I interferon response. |
| 000C72 (2020) |
Jean-Michel Sallenave [France] ; Loïc Guillot [France] | Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? |
| 000C75 (2020) |
Laurent Softic [France] ; Rozenn Brillet [France] ; François Berry [France] ; Nazim Ahnou [France] ; Quentin Nevers [France] ; Margot Morin-Dewaele [France] ; Sabah Hamadat [France] ; Patrice Bruscella [France] ; Slim Fourati [France] ; Jean-Michel Pawlotsky [France] ; Abdelhakim Ahmed-Belkacem [France] | Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025). |
| 000C82 (2020) |
Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [Luxembourg (pays)] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. |
| 000C99 (2020) |
Julien Andreani [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Priscilla Jardot [France] ; Clara Rolland [France] ; Manon Boxberger [France] ; Nathalie Wurtz [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Didier Raoult [France] | In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. |
| 000D00 (2020) |
Franck Touret [France] ; Magali Gilles [France] ; Karine Barral [France] ; Antoine Nougairède [France] ; Jacques Van Helden [France] ; Etienne Decroly [France] ; Xavier De Lamballerie [France] ; Bruno Coutard [France] | In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. |
| 000D01 (2020) |
Andrés Pizzorno [France] ; Blandine Padey [France] ; Julia Dubois [France] ; Thomas Julien [France] ; Aurélien Traversier [France] ; Victoria Dulière [France] ; Pauline Brun [France] ; Bruno Lina [France] ; Manuel Rosa-Calatrava [France] ; Olivier Terrier [France] | In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. |
